SE8503228D0 - NEW BETA-UROGASTRON GEN - Google Patents

NEW BETA-UROGASTRON GEN

Info

Publication number
SE8503228D0
SE8503228D0 SE8503228A SE8503228A SE8503228D0 SE 8503228 D0 SE8503228 D0 SE 8503228D0 SE 8503228 A SE8503228 A SE 8503228A SE 8503228 A SE8503228 A SE 8503228A SE 8503228 D0 SE8503228 D0 SE 8503228D0
Authority
SE
Sweden
Prior art keywords
urogastron
gen
new beta
beta
urogastrone
Prior art date
Application number
SE8503228A
Other languages
Swedish (sv)
Other versions
SE8503228L (en
Inventor
S Aoki
H Ohgai
A Horinaka
H Hiramatsu
S Koumoto
A Nishimura
A Matsushiro
Original Assignee
Earth Chemical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Earth Chemical Co filed Critical Earth Chemical Co
Publication of SE8503228D0 publication Critical patent/SE8503228D0/en
Publication of SE8503228L publication Critical patent/SE8503228L/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52—Genes encoding for enzymes or proenzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C12N15/73—Expression systems using phage (lambda) regulatory sequences
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/485—Epidermal growth factor [EGF], i.e. urogastrone
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/61—Fusion polypeptide containing an enzyme fusion for detection (lacZ, luciferase)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
    • C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Virology (AREA)
  • Toxicology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

The present invention provides a gene which is suited to the expression of beta -urogastrone, corresponding recombinant plasmids, corresponding transformants and preparation thereof and of beta -urogastrone.
SE8503228A 1984-07-02 1985-06-28 NEW BETA-UROGASTRON GEN SE8503228L (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP59137691A JP2554459B2 (en) 1984-07-02 1984-07-02 β-urogastron gene, corresponding plasmid recombinant and corresponding transformant

Publications (2)

Publication Number Publication Date
SE8503228D0 true SE8503228D0 (en) 1985-06-28
SE8503228L SE8503228L (en) 1986-01-03

Family

ID=15204546

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8503228A SE8503228L (en) 1984-07-02 1985-06-28 NEW BETA-UROGASTRON GEN

Country Status (12)

Country Link
JP (1) JP2554459B2 (en)
KR (1) KR920009543B1 (en)
AU (1) AU599003B2 (en)
CA (1) CA1304023C (en)
CH (1) CH670654A5 (en)
DE (1) DE3523634A1 (en)
DK (1) DK291885A (en)
FR (1) FR2566799B1 (en)
GB (1) GB2162851B (en)
IT (1) IT1210142B (en)
NL (1) NL192116C (en)
SE (1) SE8503228L (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4870008A (en) * 1983-08-12 1989-09-26 Chiron Corporation Secretory expression in eukaryotes
GB8507666D0 (en) * 1985-03-25 1985-05-01 Wellcome Found Epidermal growth factor production
US4743679A (en) * 1986-02-24 1988-05-10 Creative Biomolecules, Inc. Process for producing human epidermal growth factor and analogs thereof
US5366081A (en) 1987-08-26 1994-11-22 United States Surgical Corporation Packaged synthetic absorbable surgical elements
US5306289A (en) 1987-08-26 1994-04-26 United States Surgical Corporation Braided suture of improved characteristics
US5472702A (en) * 1987-08-26 1995-12-05 United States Surgical Corporation Sterilization of growth factors
US5226912A (en) 1987-08-26 1993-07-13 United States Surgical Corporation Combined surgical needle-braided suture device
US5222978A (en) 1987-08-26 1993-06-29 United States Surgical Corporation Packaged synthetic absorbable surgical elements
GB2210618B (en) * 1987-10-08 1991-10-16 British Bio Technology Synthetic egf gene
FI891308A (en) * 1988-03-24 1989-09-25 Oncogen NYA POLYPEPTIDER MED TILLVAEXTFAKTORAKTIVITET OCH DESSA KODANDE NUCLEIN SYRASE SEQUENTOR.
US5102789A (en) * 1989-03-15 1992-04-07 The Salk Institute Biotechnology/Industrial Associates, Inc. Production of epideramal growth factor in pichia pastoris yeast cells
US5359831A (en) 1989-08-01 1994-11-01 United States Surgical Corporation Molded suture retainer
CA2059245C (en) * 1991-02-08 2004-07-06 Michael P. Chesterfield Method and apparatus for calendering and coating/filling sutures
WO1994025592A1 (en) * 1993-04-26 1994-11-10 Daewoong Pharmaceutical Co., Ltd. A novel gene coding human epidermal growth factor and process for preparing the same
US5904716A (en) * 1995-04-26 1999-05-18 Gendler; El Method for reconstituting cartilage tissue using demineralized bone and product thereof
JP4057846B2 (en) 2002-06-07 2008-03-05 株式会社アステア Bumper structural material
US20090192554A1 (en) 2008-01-29 2009-07-30 Confluent Surgical, Inc. Bioabsorbable block copolymer

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE53166B1 (en) * 1980-08-05 1988-08-03 Searle & Co Synthetic urogastrone gene,corresponding plasmid recombinants,transformed cells,production thereof and urogastrone expression
FR2488557A1 (en) * 1980-08-13 1982-02-19 Ducellier & Cie DEVICE FOR TILTING PROJECTORS OF A MOTOR VEHICLE
US4532207A (en) * 1982-03-19 1985-07-30 G. D. Searle & Co. Process for the preparation of polypeptides utilizing a charged amino acid polymer and exopeptidase
WO1983004030A1 (en) * 1982-05-06 1983-11-24 Applied Molecular Genetics, Inc. The manufacture and expression of genes for urogastrone and polypeptide analogs thereof

Also Published As

Publication number Publication date
DK291885D0 (en) 1985-06-27
FR2566799A1 (en) 1986-01-03
GB2162851A (en) 1986-02-12
NL8501880A (en) 1986-02-03
AU599003B2 (en) 1990-07-12
CA1304023C (en) 1992-06-23
CH670654A5 (en) 1989-06-30
FR2566799B1 (en) 1989-10-20
DK291885A (en) 1986-01-03
IT8505195A0 (en) 1985-07-01
JP2554459B2 (en) 1996-11-13
KR920009543B1 (en) 1992-10-19
NL192116B (en) 1996-10-01
GB8516591D0 (en) 1985-08-07
GB2162851B (en) 1989-05-17
NL192116C (en) 1997-02-04
AU4411185A (en) 1986-01-09
KR860001186A (en) 1986-02-24
IT1210142B (en) 1989-09-06
DE3523634C2 (en) 1993-07-08
JPS6115691A (en) 1986-01-23
DE3523634A1 (en) 1986-01-09
SE8503228L (en) 1986-01-03

Similar Documents

Publication Publication Date Title
SE8503228L (en) NEW BETA-UROGASTRON GEN
DE3575290D1 (en) COMPRESSION OF CERAMIC MATERIALS.
NO864139D0 (en) POLYPEPTIDE EFFECTIVE BY THE CREATION OF AIDS ANTIBODY.
DE3583779D1 (en) GEL COMPOSITIONS OF LIPOSOMES.
GR78180B (en)
IT8519352A0 (en) APPLICATION OF AN ELASTIC SLEEVE ON AN EXTENDED BODY
DE3582223D1 (en) ELASTOMERS OF THERMOPLASTIC MODIFIED COPOLYETHERIMIDESTERS.
DE3579148D1 (en) POLYPEPTIDE AND POLYPEPTIDE COMPOSITION.
DE3689738D1 (en) Hot compression of bellows containers.
DE3680000D1 (en) STABILIZED ACTIVE FORMS OF VITAMIN-D3.
DK383985D0 (en) POLYPEPTIDE
IL78885A0 (en) Removal of the n-terminal methionine from methionyl proteins
IT8521570A0 (en) PROCEDURE FOR THE PREPARATION OF INVERTED MICROLACTICS AND THE OBTAINED INVERTED MICROLACTICS.
DE3673691D1 (en) COMPOSITION OF CERAMIC GLAZE.
IT8519647A0 (en) PREPARATION OF 2-CHLORO-4FLUOROPHENOL FROM 4-FLUOROPHENOL
FI852772L (en) FORM OF.
DE3586360D1 (en) INSULATION OF AN INTERFERON AND EXPRESSION THEREOF.
DE3584288D1 (en) ANALOGS OF THE CONNECTION P.
ES549874A0 (en) PREPARATION PROCEDURE OF 3,5-DISSTITUTED ISOXAZOLES
DE3579479D1 (en) NEW USE OF SOMATOSTATIN.
DE3579236D1 (en) REPAIR OF MASKS.
ATE66691T1 (en) PRODUCTION OF STREPTAVIDIN-LIKE POLYPEPTIDES.
SU1208765A1 (en) Method of obtaining phenolxyphenylcarbamide
ES540935A0 (en) A PROCEDURE FOR PREPARING A VECTOR FOR EXPRESSION OF A RECOMBINANT
SU1233456A1 (en) Method of obtaining substituted n-[(1,3,5-thiazine-2-il)aminocarbonyl]benzosulfonamids